ESR1 and breast carcinoma: In order to further evaluate biological functions of TACC2 in human breast carcinoma cells, we transfected specific siRNA for TACC2 in MCF‐7 (ER+ and AR+) and MDA‐MB‐453 (ER‐ and AR+) breast carcinoma cells (Fig. S1).